Torix Medical has created the Innoflow device, a disruptive solution to treat urinary obstruction related to benign prostatic hyperplasia (BPH). This condition affects most men at some point in life and imposes a significant quality of life burden. Their device will provide durable symptom relief in a simple, office-based procedure using common flexible cystoscopy tools. This means that implantation is easier for the urologist and far less painful for the patient than with any other BPH device. They have a strong IP position, a 510(k) FDA pathway, established reimbursement precedents, and an extremely quick and capital-efficient path to market. They have achieved excellent cadaver results to demonstrate that the mechanism works. They’re now beginning animal studies and will get to first-in-man in late 2015.